EWING, NJ--(Marketwire - November 14, 2007) - DOR BioPharma, Inc. (OTCBB: DORB) (“DOR” Or the “Company”) announced today its financial results for the third quarter ending September 30, 2007.
EWING, NJ--(Marketwire - November 14, 2007) - DOR BioPharma, Inc. (OTCBB: DORB) (“DOR” Or the “Company”) announced today its financial results for the third quarter ending September 30, 2007.